Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • Latest news
  • Worldwide impact of NIBSC
  • Mission and values
  • Careers
  • Quality and governance
  • Staff profiles
  • Contact us
  • Collaborations
  • Suppliers
  • Scientific Advisory Committee
  • Minutes of the Animal Welfare and Ethical Review Body
  • Our use of animals
  • Privacy notice
  • Home  /  
  • About us  /  
  • Staff profiles  /  
  • Dr Silke Schepelmann

Dr Silke Schepelmann

Dr Silke Schepelmann joined NIBSC in 2008. She is a Principal Scientist in the live viral vaccines sections of the Division of Virology and heads a group of scientists and post-doctoral scientists.

Before working at NIBSC, Silke was a post-doc at the Royal Free & University College London Medical School and at The Institute of Cancer Research in London.

Her research interests include:

  •          viral vaccines
  •          the characterisation of mumps vaccines and models for mumps virus growth
  •          investigations of public health issues related to live viral vaccines
  •          next generation sequencing of viral vaccines

Silke is on the European pharmacopoeia group 15 of experts that deals with human vaccines.  She is also an elected member of the advisory group of the European OCABR network for human biologicals.  

 
Current position

Principal Scientist, Division of Virology

Areas of interest

Mumps vaccines
Public health issues related to live viral vaccines
NGS of viral vaccines

Qualifications

1996  PhD (Dr rer nat), Darmstadt, Germany
1991  Diplom Biology, Darmstadt, Germany

Recent publications (141kb)
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap